Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AMDHD2	CGI-14	ENSG00000162066	"Amidohydrolase domain containing 2"	Q9Y303	16	2520357-2531422	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 104.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA041184, HPA041321"	Enhanced		Approved	Nucleoli,Cytosol		No	No		69000	"Nucleoli, Cytosol"		"HPA041184: AB_10803998, HPA041321: AB_10795588"	"unprognostic (1.20e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (7.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	12.8	16.9	8.6	11.4	10.1	12.7	10.9	7.3	16.0	9.4	8.8	11.1	11.3	19.5	10.4	11.9	8.4	9.0	14.6	11.8	7.1	4.8	15.3	10.5	20.0	15.8	9.8	11.3	8.1	10.1	6.5	7.5	10.7	8.9	8.6	2.4	10.9	16.1	9.6	10.2	15.0	19.1	7.2	8.3	22.2	11.5	25.7	7.9	7.3	9.9	11.0	8.9	9.3	8.0	9.8	17.1	16.6	15.8	4.9	8.1	4.8	6.5	8.8	1.9	4.0	2.1	1.7	14.3	5.9	2.5	4.7	5.9	6.3	11.6	3.0	4.2	1.1	10.1	6.0	1.1	1.6	0.1	3.8	5.3	4.3	7.9	8.2	8.0	3.1	14.1	4.0	1.7	3.4	0.5	1.2	2.9	8.5	9.8	7.2	1.9	15.6	5.1	8.6	4.1	0.5	6.8	19.7	3.0	11.0	1.3	3.6	7.3	7.2	3.8	9.2	15.5	0.3	9.5	0.8	4.0	5.3	8.1	10.5	3.0	15.2	9.7	5.9	5.9	5.9	6.6	9.9	6.1	16.5	7.4	15.8	5.5	9.8	5.9	5.3	2.3	7.4	5.0	4.2	16.6	4.9	15.2	17.1	8.1	4.8	8.6	10.1	7.3	16.0	7.1	4.8	9.8	11.3	8.9	7.9	3.0	12.3	13.1	4.6	7.9	9.0	2.0	7.6	5.3	2.3	5.2	5.9	14.1	5.0	24.6	45.6	7.1	18.1	0.0	14.7	23.4	8.0	6.0	6.9	10.4	104.3	22.3	12.1	18.4	33.6	16.0	9.8	15.9	18.6	34.3	9.0	10.8	16.8	14.4	6.0	38.1	12.0	0.0	4.4	7.7	17.2	7.9	23.3	15.3	7.0	3.8
CEMP1	CP-23	ENSG00000205923	"Cementum protein 1"	Q6PRD7	16	2530035-2531417	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	24	"Ciliated cells: 2.7;Early spermatids: 2.6;granulocytes: 1.1;Late spermatids: 6.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 8.7;REH: 9.3"									"HPA057658, HPA075926"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057658: AB_2683492, HPA075926: "																		0.7	4.1	5.8	1.6	3.3	0.6	0.5	3.6	3.7	1.2	0.7			1.7	1.1	0.0	3.3	0.6	2.6	3.3	4.5	2.4	3.6	2.5	1.6	5.4	3.0		2.1	0.8	0.8	0.9	1.3		1.0	0.0		5.5	0.6	1.9	8.0	4.6	0.0	2.4	3.4	0.9	1.0			2.4		0.0	4.6	0.6	0.6	1.2	4.2	0.0	0.7	1.8	0.0	1.2	0.9	1.1	6.0	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.9	5.3	0.0	0.7	0.0	2.3	1.9	0.0	0.0	0.0	0.7	8.7	0.7	0.0	3.0	0.0	0.7	4.2	0.0	0.0	0.0	0.0	1.3	0.0	3.6	2.1	2.0	0.0	3.6	1.0	3.0	2.4	0.5	1.8	9.3	0.6	0.1	0.0	1.8	5.0	1.8	1.4	6.5	6.4	0.3	7.4	0.8	0.4	2.3	2.0	2.9	1.3	1.0	1.7	2.1	2.8	4.3	1.2	4.2	0.0	3.5	0.3	0.0	0.6	0.6	0.6	1.1	0.0	0.4	0.2	0.9	0.0	0.7	0.0	1.2	1.8	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CHI3L1	"GP39, YKL40"	ENSG00000133048	"Chitinase 3 like 1"	P36222	1	203178931-203186749	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Inflammatory response"	Antimicrobial	"Asthma, Cancer-related genes, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 336.4"	"Cell type enriched"	"Detected in many"	7	"Hofbauer cells: 335.7"	"Cancer enriched"	"Detected in all"	8	"glioma: 1313.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	490	"neutrophil: 81.3"	"Lineage enriched"	"Detected in single"	490	"granulocytes: 81.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 40.7;ASC TERT1: 90.8;HSkMC: 80.6;THP-1: 128.4;U-138 MG: 38.1;U-87 MG: 37.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	14	"olfactory region: 10.7"	HPA077365			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	25100000	230000000	"Golgi apparatus"	Vesicles	"HPA077365: "	"unprognostic (2.11e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.39e-3)"	19.0	0.8	20.3	53.4	58.0	81.6	23.9	1.2	69.4	4.3	2.1	5.0	0.0	0.9	4.3	25.5	3.5	10.2	1.9	2.6	9.1	17.8	11.9	336.4	10.0	12.4	32.3	3.6	4.5	2.5	0.8	22.9	4.7	66.4	1.5	1.6	9.1	19.3	1.1	10.5	10.0	2.2	3.3	23.5	2.9	1.7	3.4	6.5	0.9	2.0	1.7	14.6	61.5	4.0	0.0	0.0	81.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	40.7	90.8	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	80.6	0.0	0.2	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.4	0.0	38.1	0.2	0.0	0.0	0.2	4.8	0.0	37.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.3	0.0	0.1	0.0	0.0	0.1	20.3	58.0	1.2	28.9	9.1	17.8	32.3	3.6	66.4	6.5	6.0	39.7	0.0	19.4	3.8	0.0	0.8	2.5	4.0	15.9	26.2	0.0	1.2	0.0	49.4	0.0	0.4	0.0	0.0	0.0	0.9	2.2	2.2	0.0	28.7	335.7	0.0	0.0	0.0	0.3	0.0	0.9	3.9	13.5	1.8	0.0	40.4	3.1	0.0	0.0	0.1	1.8	0.0	1.7	0.0	0.0	1.0	0.7	0.0	0.0	1.6
CHIA	"AMCase, CHIT2, TSA1902"	ENSG00000134216	"Chitinase, acidic"	Q9BZP6	1	111290862-111320566	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"stomach 1: 66.6"	"Cell type enriched"	"Detected in some"	8	"Alveolar cells type 2: 22.2"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.8;stomach cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"ASC diff: 6.0;HAP1: 3.1"					"Low region specificity"	"Detected in single"			HPA059193	Approved				"Intracellular and membrane"	NA	NA					"HPA059193: AB_2683942"				"unprognostic (8.00e-2)"	"unprognostic (7.08e-2)"			"unprognostic (2.02e-2)"					"unprognostic (4.99e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.7	0.5	0.8	0.3	0.1	0.1	0.1	0.0	0.5	1.0	13.2	0.2	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	66.6	0.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	1.6	0.7	0.0	0.1	0.6	0.6	0.3	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.0	0.2	0.5	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.7	0.2	0.2	0.0	1.6	0.6	0.0	0.0	0.6	0.0	0.7	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	22.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 99.9;lymphoid tissue: 106.5"	"Cell type enriched"	"Detected in single"	44	"Hofbauer cells: 42.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 2.9;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;LHCN-M2: 1.7;RH-30: 1.8;U-266/70: 2.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Enhanced				"Secreted to blood"	NA	NA	26400000	58000000			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	99.9	0.2	0.2	0.4	0.3	26.7	5.5	0.1	0.3	5.9	0.6	0.5	0.1	0.0	2.5	0.2	0.3	0.1	0.2	0.6	0.2	0.1	0.1	0.4	22.1	106.5	0.4	0.1	1.4	1.1	0.0	0.2	0.4	0.5	0.6	0.5	0.3	0.3	0.1	0.1	0.3	0.7	0.2	9.4	4.3	0.1	0.1	0.1	2.3	0.9	0.2	0.5	0.1	0.3	0.5	0.2	2.9	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	1.7	0.2	0.0	0.0	0.1	0.0	0.2	0.0	1.8	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.9	0.0	1.1	0.2	0.0	1.3	0.2	0.3	0.1	0.3	0.2	0.1	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	42.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CMAS		ENSG00000111726	"Cytidine monophosphate N-acetylneuraminic acid synthetase"	Q8NFW8	12	22046174-22065674	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Syncytiotrophoblasts: 445.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039905	Supported		Uncertain	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA039905: AB_10795237"	"unprognostic (5.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.03e-1)"	8.1	28.2	28.1	9.6	31.6	17.6	14.9	16.3	39.3	12.1	34.3	14.5	17.1	29.4	12.8	32.0	33.2	10.0	11.0	18.1	28.8	33.4	12.8	31.9	7.9	9.8	33.9	27.3	11.9	18.6	14.6	14.3	20.2	34.3	17.0	33.1	10.2	14.8	12.9	18.2	12.9	32.9	13.3	18.0	8.5	12.9	30.2	14.8	6.4	10.9	11.9	12.4	11.8	17.2	12.2	19.5	19.4	18.9	22.8	19.9	15.0	19.4	15.8	19.4	9.2	15.3	19.1	28.2	13.6	15.0	14.8	15.7	35.3	22.6	17.3	13.4	11.6	27.3	15.9	11.4	18.9	20.0	22.8	14.4	52.1	12.8	17.7	14.3	13.7	27.7	12.8	18.0	18.8	28.1	20.2	19.6	18.8	32.7	8.8	26.2	25.6	15.8	32.0	46.8	21.8	21.9	11.2	20.3	16.4	17.6	21.4	7.8	13.7	10.7	19.0	15.3	40.7	26.1	18.9	14.2	16.7	13.8	14.7	24.9	6.1	7.8	23.0	27.2	10.8	16.8	10.3	17.9	19.4	13.7	18.9	17.8	12.2	18.6	18.1	19.5	12.1	16.8	17.4	1.8	22.8	16.5	12.3	19.9	15.0	28.1	31.6	16.3	39.3	28.8	33.4	33.9	27.3	34.3	14.8	11.9	13.7	19.0	62.8	26.0	35.2	62.1	28.1	46.8	28.4	22.7	3.9	144.0	64.6	44.6	10.3	38.6	126.2	116.8	73.5	117.3	40.1	92.3	22.0	56.7	56.8	33.4	40.0	38.6	32.1	12.9	23.6	27.0	42.2	49.5	94.4	20.7	65.2	133.3	26.2	64.8	17.4	19.4	37.0	79.6	93.5	38.9	445.4	22.3	85.9	97.2
GALE	SDR1E1	ENSG00000117308	UDP-galactose-4-epimerase	Q14376	1	23795599-23800804	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Mucus-secreting cells: 119.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007340			Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA007340: AB_1078934"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (1.41e-2)"	4.4	5.5	4.8	5.6	6.1	1.8	5.0	4.3	8.7	9.1	22.3	3.2	12.4	20.0	3.0	6.0	26.2	6.4	34.7	3.7	4.0	4.1	18.2	26.1	7.7	3.9	3.7	5.2	2.4	15.9	7.7	3.5	29.4	3.5	4.8	23.8	5.5	32.1	6.9	1.7	3.9	30.4	4.1	3.6	8.6	46.7	3.4	2.6	3.7	2.3	9.8	19.6	8.1	8.4	3.1	10.6	2.0	18.6	19.4	5.2	4.7	16.3	19.7	7.9	12.5	2.9	4.2	7.7	11.2	15.2	19.9	14.9	18.0	55.1	3.9	15.8	6.5	26.7	18.2	7.0	28.7	15.1	8.3	4.5	11.0	10.0	19.5	30.1	4.7	3.3	8.9	15.1	18.3	46.0	20.1	17.0	8.5	12.2	1.0	14.1	17.5	7.8	5.1	2.2	23.0	19.2	9.3	7.7	4.9	32.2	11.0	3.1	7.0	20.3	18.4	19.9	9.4	13.5	3.9	9.3	14.5	21.7	14.9	13.7	5.1	12.2	5.1	15.4	20.2	7.8	1.1	7.7	1.7	5.1	15.5	5.2	3.1	3.1	4.1	10.6	1.0	3.6	2.5	2.0	19.4	18.6	3.0	5.1	4.7	4.8	6.1	4.3	8.7	4.0	4.1	3.7	5.2	3.5	2.6	11.9	33.5	8.2	17.9	6.8	14.3	3.1	40.8	12.0	19.4	38.4	15.7	47.8	29.9	42.8	20.5	9.8	92.2	0.0	103.0	85.9	6.3	18.2	10.4	31.8	81.7	7.9	11.6	9.2	3.7	5.1	4.4	12.2	23.6	29.7	119.4	20.6	62.8	84.5	3.2	64.1	13.1	0.0	5.3	14.6	9.7	4.3	80.6	7.5	58.2	38.3
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44144271-44198170	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 46.8"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 5.5;Cardiomyocytes: 3.1;Fibroblasts: 3.9;Horizontal cells: 4.8;Muller glia cells: 3.0;Smooth muscle cells: 4.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.4;naive CD4 T-cell: 4.8"	"Group enriched"	"Detected in many"	17	"B-cells: 4.4;T-cells: 4.8"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 12.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	1.1	0.5	3.2	0.7	2.8	0.0	0.7	9.5	3.7	1.4	1.4	1.3	0.7	0.3	1.5	1.5	0.7	2.3	0.9	7.1	2.1	7.5	0.7	8.7	0.7	0.7	2.9	1.2	2.2	2.9	0.0	46.8	3.3	1.6	0.8	0.5	0.8	0.7	1.6	0.7	1.2	0.7	0.7	1.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.9	4.4	0.2	0.0	0.0	0.0	4.8	0.7	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.6	0.9	0.0	1.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.3	2.2	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.6	4.4	1.6	0.4	0.2	0.7	4.8	0.9	0.0	0.0	0.0	0.0	0.0	0.7	3.2	2.8	9.5	2.4	2.1	7.5	2.9	1.2	1.6	0.7	0.0	0.0	0.0	0.7	1.0	5.5	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	3.9	0.3	0.0	0.6	0.6	4.8	2.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.0	0.1	0.0	2.1	0.0	0.8	0.0	4.3	0.2	0.9	0.1	0.7	0.0	0.0	0.1
GFPT1	"GFA, GFAT, GFAT1, GFPT"	ENSG00000198380	"Glutamine--fructose-6-phosphate transaminase 1"	Q06210	2	69319769-69387254	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Aminotransferase, Transferase"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 215.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047240			Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli"	"Nucleoli fibrillar center"	"HPA047240: "	"unprognostic (4.38e-3)"	"unprognostic (8.20e-2)"	"prognostic favorable (7.13e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	16.7	11.4	6.4	12.7	7.8	5.6	18.3	7.8	10.1	16.8	27.0	6.4	41.2	14.5	10.1	18.7	11.6	9.5	19.4	11.3	6.0	9.8	17.8	49.1	14.1	4.7	6.5	5.7	11.1	34.9	13.9	39.6	36.5	7.0	17.2	27.5	7.7	39.7	34.0	9.2	6.1	28.2	8.7	6.2	8.2	24.6	13.9	4.8	8.5	35.2	7.7	18.1	10.6	16.2	5.6	4.1	5.9	3.4	4.1	6.8	3.0	9.6	6.7	8.7	5.4	24.2	16.7	18.7	18.5	17.2	8.7	11.1	21.4	8.8	8.7	6.7	17.1	10.9	4.7	10.8	5.6	14.4	7.9	4.1	10.1	5.0	22.1	28.7	6.9	4.0	10.5	27.6	16.9	32.4	12.1	8.1	7.5	8.4	14.2	17.0	5.7	7.2	7.2	11.2	19.9	5.6	7.3	18.0	4.4	14.2	7.7	5.3	3.0	6.9	12.8	24.7	18.7	5.1	4.3	12.4	7.8	10.4	13.3	8.8	10.2	6.8	6.6	12.7	4.7	8.9	5.9	2.8	3.4	6.8	3.2	6.5	5.6	6.1	6.6	3.6	3.4	6.1	5.6	1.3	4.1	3.4	4.1	4.3	3.0	6.4	7.8	7.8	10.1	6.0	9.8	6.5	5.7	7.0	4.8	47.6	43.8	21.6	18.1	25.2	14.6	39.1	43.3	62.9	45.5	41.8	11.8	23.5	14.9	29.0	71.7	15.1	126.6	0.0	78.9	58.2	37.0	83.5	24.2	49.7	15.2	6.4	72.2	19.6	8.8	12.1	21.6	14.3	50.6	39.7	215.3	10.9	58.8	74.8	26.5	24.3	13.7	19.4	31.7	89.0	45.3	18.3	28.7	16.6	120.1	30.1
GFPT2	GFAT2	ENSG00000131459	"Glutamine-fructose-6-phosphate transaminase 2"	O94808	5	180300690-180353387	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 65.6"	"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 28.9;Peritubular cells: 17.7;Smooth muscle cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 7.1"	"Lineage enriched"	"Detected in single"	49	"T-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.3;ASC TERT1: 41.6;GAMG: 30.6;HSkMC: 26.7;hTEC/SVTERT24-B: 49.5;U-87 MG: 86.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056892, HPA059910"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA056892: AB_2683266, HPA059910: AB_2684157"	"unprognostic (3.48e-1)"	"prognostic unfavorable (9.09e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (7.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.58e-14)"	"unprognostic (3.67e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.52e-3)"	65.6	3.9	4.5	15.8	5.6	0.9	11.0	17.0	9.2	10.0	9.2	9.3	5.4	2.1	9.0	16.7	5.9	15.9	14.6	16.4	7.1	3.8	2.8	2.6	11.0	3.1	6.2	6.8	17.5	11.1	3.5	2.5	6.0	8.4	7.7	3.6	2.9	4.0	8.0	6.0	4.0	5.0	10.0	17.2	1.7	6.6	6.3	7.7	0.0	5.6	5.4	3.5	14.3	14.6	0.0	0.1	0.0	0.0	0.1	7.1	0.2	0.0	5.4	4.2	5.5	24.3	41.6	0.4	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.3	4.5	30.6	0.0	2.3	0.0	0.2	0.5	0.8	0.0	2.6	0.0	10.1	0.0	0.0	26.7	0.2	49.5	0.1	8.4	8.0	0.2	0.0	0.0	21.2	0.7	0.0	0.0	9.1	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.2	0.3	8.3	0.1	0.3	5.2	0.3	0.0	3.8	13.7	2.1	8.8	10.0	0.0	0.0	0.0	86.1	0.0	0.3	0.0	0.0	0.0	1.4	0.0	7.1	0.0	0.8	2.4	0.1	0.0	0.8	1.1	0.0	0.1	0.0	0.1	0.0	0.2	4.5	5.6	17.0	9.2	7.1	3.8	6.2	6.8	8.4	7.7	3.0	4.5	0.0	0.3	6.5	0.0	2.2	0.0	2.7	5.7	1.8	0.0	0.9	1.7	0.8	4.5	0.6	0.0	0.0	0.7	0.4	28.9	0.9	1.1	0.0	0.4	0.0	0.0	1.8	0.8	2.0	9.5	1.8	8.5	0.0	0.0	5.2	0.5	0.0	17.7	0.3	0.0	0.0	16.5	9.1	5.3	3.8	2.3	3.8	0.0	0.4
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.0;salivary gland: 45.3"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 95.4;Mucus-secreting cells: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favorable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	7.7	6.7	6.0	6.5	8.3	8.3	16.6	11.1	12.1	7.9	20.7	7.0	4.6	2.9	8.0	3.9	7.6	6.7	5.2	7.6	7.8	6.8	6.8	55.0	5.5	6.0	6.0	7.8	9.8	8.4	4.1	7.0	20.2	10.2	10.1	30.1	4.8	45.3	5.0	10.5	3.7	7.2	11.7	10.9	4.5	4.9	3.4	5.3	3.2	4.6	4.2	7.9	8.6	7.9	3.9	2.2	1.2	2.7	2.4	4.2	1.8	4.4	19.9	8.9	7.6	10.1	10.1	12.9	6.2	7.9	8.6	11.1	4.8	14.2	5.8	6.6	10.3	22.4	1.7	6.7	2.0	9.6	10.9	0.6	5.0	11.7	6.6	6.9	0.1	14.3	6.6	2.0	14.3	13.5	6.3	3.6	9.0	6.3	12.1	8.3	0.7	8.1	2.6	5.1	2.8	11.2	6.7	7.5	1.6	47.6	8.2	7.6	6.9	6.6	2.3	5.7	3.3	2.1	5.1	5.2	5.7	5.9	6.8	5.4	5.3	11.3	3.2	7.8	4.3	8.1	0.7	1.7	0.9	2.7	2.2	1.8	2.4	3.4	2.9	1.4	3.9	4.0	4.2	1.2	2.4	2.7	2.2	1.5	1.8	6.0	8.3	11.1	12.1	7.8	6.8	6.0	7.8	10.2	5.3	8.9	10.6	4.5	2.8	1.6	7.9	5.9	10.2	18.7	14.8	8.7	5.9	7.5	1.7	9.3	2.8	4.5	18.3	0.0	5.2	7.3	5.1	7.6	9.3	95.4	2.7	11.1	11.1	8.0	5.0	2.3	10.0	4.3	1.7	6.4	67.2	2.0	4.2	23.0	6.0	1.7	6.2	12.9	4.1	1.1	2.7	1.4	16.6	5.0	21.2	5.6
GNPDA1	"GNPDA, GNPI, GPI, HLN, KIAA0060"	ENSG00000113552	"Glucosamine-6-phosphate deaminase 1"	P46926	5	141991749-142013041	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 107.2;Proximal tubular cells: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		970000	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.05e-3)"	15.6	28.2	13.9	10.0	19.1	4.3	18.7	12.6	22.5	16.5	13.7	13.2	11.7	18.0	24.8	34.0	10.7	11.9	13.7	10.6	12.3	16.1	46.2	10.2	11.0	21.8	14.1	16.5	20.7	7.7	15.1	19.9	18.9	13.4	17.8	14.0	17.1	10.6	18.9	16.5	9.0	18.8	18.4	10.9	18.2	9.5	16.3	10.8	12.4	18.2	9.2	11.8	23.6	11.2	7.9	20.6	5.0	22.7	5.6	32.7	14.7	9.5	14.0	5.5	27.0	18.8	12.7	12.8	7.6	18.3	20.2	23.0	20.9	11.4	0.0	17.4	5.4	90.8	10.1	25.4	22.6	17.9	7.3	10.9	7.0	8.2	14.9	33.4	19.4	9.3	15.2	13.4	12.8	34.4	15.1	21.1	18.7	8.3	25.9	21.6	6.0	14.7	2.2	20.5	14.4	28.3	5.7	17.8	21.3	19.4	26.5	4.8	12.7	15.1	15.7	28.8	16.8	12.8	6.1	10.0	11.8	8.0	18.1	10.7	14.5	27.8	10.7	17.3	6.6	10.3	0.0	19.4	2.6	15.7	22.7	32.7	7.9	12.8	14.4	20.6	3.7	15.5	16.5	5.0	5.6	20.4	11.6	10.6	14.7	13.9	19.1	12.6	22.5	12.3	16.1	14.1	16.5	13.4	10.8	8.9	9.3	7.5	31.0	5.4	9.7	10.9	15.3	8.1	20.5	17.4	7.9	22.9	29.9	25.3	0.9	13.0	9.9	0.0	12.2	39.3	11.5	18.6	11.5	5.9	107.2	6.4	14.5	17.2	52.5	2.5	18.4	36.7	13.5	23.4	6.6	35.2	18.7	6.0	25.1	73.4	6.3	0.0	8.1	5.1	16.8	6.5	24.8	17.0	8.3	32.4
GNPDA2	SB52	ENSG00000163281	"Glucosamine-6-phosphate deaminase 2"	Q8TDQ7	4	44682200-44726595	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		710000	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.13e-2)"	12.3	13.7	14.8	11.2	21.5	7.3	14.9	47.5	24.5	15.2	12.3	7.3	8.7	8.0	17.5	15.3	11.2	13.3	10.8	17.8	14.5	13.9	14.3	4.3	10.0	11.7	13.7	17.6	24.2	8.1	13.0	29.9	6.6	16.5	15.7	8.5	11.5	9.8	16.2	10.9	10.2	8.7	16.6	12.7	11.4	9.9	11.1	11.3	10.0	18.9	8.4	10.2	13.5	11.0	11.6	3.3	5.8	4.1	8.4	11.4	4.4	9.0	6.3	6.8	5.7	10.7	14.9	2.2	16.1	17.5	10.4	9.7	3.2	11.2	7.9	9.4	13.8	17.9	3.1	6.3	15.0	11.7	10.5	7.1	11.2	10.3	5.6	11.9	11.7	10.5	17.4	10.6	10.6	8.0	13.4	15.4	10.3	6.7	10.4	19.5	0.4	14.0	6.6	3.2	5.9	11.8	9.3	14.5	4.4	10.3	5.4	11.7	9.5	7.0	4.1	15.2	3.5	8.8	7.0	15.8	14.2	13.3	22.9	18.3	13.6	21.4	11.3	23.3	8.4	12.6	5.8	2.3	4.5	9.7	3.3	11.3	11.6	9.1	9.0	3.3	10.4	11.4	10.9	1.1	8.4	4.1	2.6	9.6	4.4	14.8	21.5	47.5	24.5	14.5	13.9	13.7	17.6	16.5	11.3	8.9	2.9	11.8	7.4	11.1	14.3	11.7	0.0	4.0	6.8	14.0	7.9	0.9	13.3	10.5	24.9	11.4	1.7	23.3	13.1	1.0	15.9	4.1	15.1	1.6	4.3	12.7	6.4	11.1	1.9	2.4	15.0	3.5	8.5	3.6	4.2	18.1	10.0	3.5	22.3	11.6	16.3	12.9	14.4	16.2	27.2	9.4	0.5	16.0	4.2	4.1
GNPNAT1	"FLJ10607, Gpnat1"	ENSG00000100522	"Glucosamine-phosphate N-acetyltransferase 1"	Q96EK6	14	52775194-52791668	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.3"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044647	Approved					NA	NA		17000			"HPA044647: AB_10795986"	"unprognostic (4.55e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.18e-3)"	"unprognostic (4.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (8.52e-5)"	"unprognostic (5.82e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.05e-2)"	13.4	6.9	6.4	6.7	6.6	2.1	10.6	9.2	9.2	10.0	11.2	4.6	6.8	9.3	8.1	6.4	8.4	6.3	9.3	6.3	5.8	6.3	11.5	47.3	6.4	8.6	5.4	5.2	9.3	28.4	6.9	12.4	6.5	7.1	10.1	14.0	4.1	22.2	4.7	9.4	4.8	8.5	8.2	6.3	7.3	12.0	12.5	4.2	3.6	5.4	6.0	7.1	7.3	7.2	6.1	5.1	6.6	5.7	7.7	8.4	4.2	33.0	13.2	10.5	11.9	11.4	25.8	17.3	21.6	13.9	18.9	19.5	15.0	19.6	18.8	12.1	21.3	9.0	13.4	20.1	21.7	32.7	10.7	10.8	12.6	12.7	18.6	16.5	14.0	6.8	10.8	18.6	31.9	34.2	9.7	21.0	12.0	12.1	4.6	24.1	28.7	16.7	7.3	11.0	43.3	23.3	11.6	4.9	11.3	17.8	17.7	10.8	14.8	17.8	24.2	15.4	7.5	27.6	4.8	23.4	19.2	20.1	33.8	16.6	4.8	9.3	8.3	9.0	9.2	11.1	6.6	2.2	0.1	7.1	2.7	8.4	6.1	7.3	6.2	5.1	5.4	8.4	6.8	0.7	7.7	5.7	3.2	8.4	4.2	6.4	6.6	9.2	9.2	5.8	6.3	5.4	5.2	7.1	4.2	14.9	8.9	6.0	18.9	17.1	10.1	3.4	25.5	16.0	13.6	12.2	3.9	21.4	28.2	29.2	16.2	12.4	8.5	0.0	32.6	61.8	19.0	28.0	6.9	81.6	14.0	3.2	5.2	9.2	7.1	5.4	18.1	8.3	6.8	4.6	38.1	5.0	34.9	14.0	17.0	12.2	6.5	19.4	14.6	24.2	4.1	18.6	10.2	7.7	25.6	33.5
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340919-72376476	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	30.1	37.4	23.1	18.0	22.9	35.5	37.8	23.3	28.1	30.6	20.5	19.4	30.1	18.5	25.9	65.7	11.7	21.8	29.2	33.8	23.4	12.8	34.6	29.5	43.9	31.4	24.9	21.1	20.9	22.2	18.1	22.9	37.9	18.8	18.1	26.0	26.9	24.8	22.0	17.7	17.9	24.6	23.4	21.4	31.5	22.6	18.0	22.9	12.1	31.2	11.1	16.4	26.7	17.1	16.1	37.9	22.4	32.7	17.8	18.1	21.3	7.5	12.8	5.5	10.6	45.5	51.9	7.9	10.6	53.8	23.0	36.8	6.7	55.4	6.3	10.2	21.3	12.0	15.1	14.6	6.7	14.6	5.1	5.8	7.9	12.7	11.6	35.2	18.9	22.7	44.1	20.2	10.0	17.9	42.2	21.0	9.4	12.2	39.2	30.6	6.5	4.1	9.5	3.1	24.7	0.1	4.2	12.0	14.2	25.7	11.9	4.8	5.3	26.5	25.1	59.9	11.7	4.6	23.9	10.6	34.5	14.4	31.7	11.2	20.9	28.2	6.5	12.5	25.3	16.7	8.9	32.7	22.4	18.1	13.7	15.8	16.1	12.0	15.8	37.9	15.6	9.5	14.0	3.1	17.8	4.8	14.4	10.7	21.3	23.1	22.9	23.3	28.1	23.4	12.8	24.9	21.1	18.8	22.9	59.6	55.5	41.1	30.3	19.7	40.2	22.6	35.7	17.4	28.4	62.8	100.1	116.3	51.4	65.3	16.3	43.0	46.2	0.0	33.3	55.3	62.5	30.5	29.9	37.8	207.1	25.4	45.3	44.2	76.0	10.5	68.7	108.5	89.4	50.5	39.4	48.4	43.8	84.5	42.1	55.5	56.1	45.3	20.6	20.4	28.2	13.7	131.8	47.5	44.4	25.0
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 174.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 395.6;Hofbauer cells: 319.1;Syncytiotrophoblasts: 412.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 108.4;GAMG: 90.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"	NA	NA		43000000			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	48.0	21.9	7.7	13.6	11.6	11.1	26.1	7.4	11.2	25.8	34.2	9.5	18.0	21.6	22.1	77.3	20.6	17.3	28.1	46.3	7.1	9.1	30.4	44.5	40.9	19.3	8.5	6.7	22.7	30.4	21.8	14.3	174.3	9.3	22.6	26.3	21.0	34.6	13.3	21.0	15.3	33.6	21.0	8.7	20.5	20.7	16.2	6.1	10.8	33.7	15.2	15.4	24.0	19.7	8.9	59.8	23.8	65.9	7.6	16.4	42.9	20.3	16.0	5.6	18.5	108.4	33.5	18.2	25.0	81.1	24.4	53.0	18.8	26.6	0.0	19.8	20.5	90.2	16.4	6.0	25.4	32.3	11.4	10.8	2.6	15.5	14.1	31.8	2.2	22.0	29.5	15.0	25.6	17.2	38.5	27.9	6.4	7.5	33.3	26.7	20.6	2.6	5.1	5.2	19.3	7.2	6.2	8.1	26.5	16.8	18.6	3.6	4.5	19.4	13.2	24.1	10.1	13.9	15.1	16.6	16.1	4.0	29.6	23.0	15.4	26.5	0.1	36.7	20.0	29.2	14.5	65.9	18.6	14.2	24.5	16.4	8.9	11.7	13.1	59.8	5.5	11.2	10.9	23.8	7.6	14.6	18.0	13.7	42.9	7.7	11.6	7.4	11.2	7.1	9.1	8.5	6.7	9.3	6.1	38.7	35.5	39.5	70.4	39.0	9.5	18.9	63.7	20.1	18.2	27.9	7.9	395.6	16.6	123.0	1.1	60.6	71.9	0.0	111.0	143.1	100.1	65.8	69.2	62.8	319.1	9.5	21.9	83.4	134.6	1.7	78.9	151.2	69.2	83.8	50.0	34.8	68.2	51.8	67.8	65.5	10.6	45.3	54.5	0.2	1.1	28.4	412.8	37.3	76.2	54.8
HEXDC	FLJ23825	ENSG00000169660	"Hexosaminidase D"	Q8WVB3	17	82418318-82442645	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 30.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022834, HPA023379, HPA027844"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoli fibrillar center, Mitochondria"		"HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711"	"unprognostic (8.69e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (7.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.51e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.57e-4)"	"unprognostic (9.04e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.52e-5)"	12.7	8.5	7.1	16.6	9.3	14.3	8.7	13.2	7.3	10.1	7.6	8.8	12.8	8.0	10.0	11.1	7.9	10.3	9.4	5.7	7.2	4.6	9.9	11.6	12.4	11.6	12.8	5.5	13.6	72.9	10.2	14.6	5.7	7.4	14.1	4.2	7.0	13.3	9.2	20.4	11.3	12.3	6.0	6.1	15.6	8.8	4.7	11.4	8.6	11.7	8.6	10.7	8.3	8.8	5.9	30.3	3.3	11.5	11.9	9.8	4.4	3.0	7.7	3.4	5.3	10.4	9.0	10.5	3.9	4.8	4.1	4.7	2.7	10.4	8.1	4.3	1.6	2.8	4.3	2.0	2.3	1.9	5.6	13.1	3.6	6.8	4.5	9.3	2.4	9.3	6.4	2.3	1.1	4.2	5.6	5.3	6.2	4.6	2.8	1.1	7.0	8.4	9.0	3.1	5.6	4.7	10.0	2.9	15.8	3.1	4.6	4.8	10.2	8.1	5.3	7.3	1.6	8.5	9.2	5.3	2.7	5.1	2.0	2.7	12.7	2.4	6.0	2.1	6.9	2.7	3.3	1.7	2.7	9.8	11.5	6.5	4.6	2.2	3.4	2.0	5.9	3.5	5.1	3.0	11.9	4.9	30.3	1.4	4.4	7.1	9.3	13.2	7.3	7.2	4.6	12.8	5.5	7.4	11.4	3.0	8.5	8.3	9.5	4.1	19.2	4.4	12.7	9.4	12.5	17.4	17.7	4.7	8.3	5.4	1.2	8.0	16.8	0.0	8.2	5.3	6.2	10.5	10.3	12.9	13.7	39.7	13.3	16.0	9.5	2.1	33.1	11.5	5.0	16.2	14.4	18.7	5.8	10.1	23.3	6.1	29.0	19.4	6.2	6.0	10.2	2.0	3.3	12.9	12.0	7.5
HK1		ENSG00000156515	"Hexokinase 1"	P19367	10	69269984-69401884	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycolysis, Immunity, Inflammatory response, Innate immunity"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 307.9;Horizontal cells: 287.6;Late spermatids: 870.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007043, HPA007044, CAB010052"	Supported		Supported	Mitochondria		NA	NA		16000000	Mitochondria		"CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049"	"unprognostic (8.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.86e-2)"	17.5	10.5	21.1	19.9	30.4	23.5	15.8	40.0	48.6	16.6	16.9	10.1	7.6	6.3	13.5	9.4	44.8	15.2	12.6	61.6	19.8	23.3	10.8	4.4	17.2	14.3	19.8	31.3	9.0	4.6	12.5	14.7	22.6	31.3	25.5	15.4	21.2	21.5	26.8	62.1	30.7	8.6	25.6	9.7	13.3	20.3	28.9	10.6	18.9	33.6	32.6	23.0	25.8	23.1	11.4	25.5	17.8	39.3	8.9	23.0	29.6	17.7	10.1	13.6	12.9	15.2	11.4	8.6	17.7	46.6	23.7	25.7	2.9	2.0	1.3	14.0	29.7	17.2	15.6	12.7	39.6	22.7	11.8	9.9	44.2	10.8	0.2	17.3	0.8	33.5	17.2	23.1	33.9	75.8	29.8	24.6	6.6	73.7	9.3	32.4	29.5	5.1	2.2	20.8	9.1	45.1	7.8	8.3	0.1	16.4	21.0	13.9	16.4	20.2	39.4	11.7	20.1	21.5	2.9	25.2	35.5	16.2	19.5	24.7	11.3	7.4	3.1	46.0	23.3	10.2	17.8	27.3	13.4	14.0	39.3	23.0	11.4	16.2	15.8	25.5	6.8	14.5	11.5	6.6	8.9	39.3	2.9	17.8	29.6	21.1	30.4	40.0	48.6	19.8	23.3	19.8	31.3	31.3	10.6	23.8	29.6	15.8	44.3	42.8	67.3	110.0	7.6	32.1	31.8	26.2	51.1	51.0	11.6	26.4	307.9	34.4	10.3	23.3	26.9	78.8	26.0	25.9	22.0	0.8	45.7	287.6	18.0	25.8	31.3	870.1	14.1	40.6	35.4	24.4	21.8	29.7	36.4	11.5	17.3	0.7	85.2	19.4	42.8	4.3	4.4	45.2	99.4	25.4	12.6	42.9
HK2		ENSG00000159399	"Hexokinase 2"	P52789	2	74833981-74893359	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 87.9;Enterocytes: 116.3;Paneth cells: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 26.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 54.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028587, HPA061711"	Enhanced		Supported	Vesicles,Centrosome,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	"Vesicles, Centrosome"	"HPA028587: AB_10602605, HPA061711: "	"unprognostic (1.28e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (2.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.67e-2)"	27.0	2.2	4.4	9.5	5.0	20.4	10.8	0.7	4.5	5.3	23.2	7.3	5.7	1.3	2.6	40.1	13.6	4.8	9.1	8.3	2.8	2.3	2.1	1.4	16.5	5.0	8.5	1.1	14.9	3.5	1.1	1.7	13.2	5.4	4.0	19.2	9.6	10.3	0.5	29.3	9.7	8.9	1.7	10.9	7.4	8.7	24.8	7.4	4.3	7.1	22.3	9.2	29.0	8.3	0.8	6.2	26.2	7.1	0.0	0.8	2.0	16.5	0.1	3.8	14.0	32.9	3.4	14.3	6.4	9.4	7.3	10.5	13.2	3.0	12.0	6.2	3.0	9.4	5.7	17.5	13.6	21.2	3.4	3.7	16.3	3.8	18.2	10.4	23.8	26.9	5.8	14.8	13.8	24.3	8.2	3.4	6.9	14.2	0.0	2.1	11.8	5.7	24.4	13.9	15.7	11.5	9.3	8.1	9.3	4.4	23.4	2.8	13.7	4.1	20.9	8.2	5.8	1.1	3.8	2.8	23.3	4.1	9.6	11.7	8.3	2.3	6.0	54.3	17.5	6.0	6.6	7.1	26.2	0.1	5.7	0.3	0.6	0.4	0.1	6.2	0.8	0.7	0.7	5.9	0.0	3.7	0.1	0.8	2.0	4.4	5.0	0.7	4.5	2.8	2.3	8.5	1.1	5.4	7.4	14.9	37.6	2.9	5.5	45.8	6.2	6.0	7.6	0.0	6.8	5.2	78.5	0.7	0.0	4.4	87.9	3.6	116.3	0.0	3.8	12.3	8.5	17.2	21.9	0.0	15.7	20.6	37.5	1.3	14.6	32.5	13.6	18.9	21.9	1.0	32.2	4.3	18.4	86.0	7.4	0.0	43.3	12.9	2.3	3.1	4.5	49.8	6.9	2.2	19.9	69.9
HK3		ENSG00000160883	"Hexokinase 3"	P52790	5	176880869-176899332	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.2;bone marrow: 55.0;lymphoid tissue: 40.6"	"Group enriched"	"Detected in some"	13	"Hofbauer cells: 32.3;Kupffer cells: 47.9;Macrophages: 21.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 76.2"	"Group enriched"	"Detected in many"	11	"granulocytes: 76.2;monocytes: 31.4"	"Cell line enriched"	"Detected in some"	4	"U-937: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056743	Enhanced					NA	NA		1700000			"HPA056743: AB_2683222"	"unprognostic (4.22e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (3.84e-8)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.42e-2)"	9.2	2.6	0.6	8.5	1.0	55.0	1.3	0.3	1.2	0.4	1.7	0.3	0.0	0.9	0.8	2.6	1.9	3.0	0.9	5.4	0.6	0.3	1.6	4.1	16.3	24.1	1.2	0.5	1.2	1.0	0.0	0.4	2.9	0.5	0.9	0.6	0.9	0.9	0.1	0.8	0.3	1.6	3.4	0.6	40.6	1.2	0.6	0.2	1.3	1.5	0.2	1.2	1.8	5.3	0.0	5.1	76.2	31.4	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	0.1	0.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	21.3	0.0	76.2	15.4	32.9	0.0	29.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	5.4	0.0	31.4	0.2	0.0	6.0	0.6	1.0	0.3	1.2	0.6	0.3	1.2	0.5	0.5	0.2	0.0	1.4	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.2	32.3	0.0	0.0	0.6	47.9	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220303-69267559	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 77.4"	"Cell type enhanced"	"Detected in many"	25	"Cholangiocytes: 30.6;Ductal cells: 30.8;Enterocytes: 44.0;Muller glia cells: 172.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 8.3;T-reg: 6.6"	"Lineage enriched"	"Detected in single"	29	"T-cells: 8.3"	"Cell line enhanced"	"Detected in some"		"A549: 14.8;CACO-2: 21.1;CAPAN-2: 41.7;EFO-21: 12.9;GAMG: 17.4;Hep G2: 12.2;RPTEC TERT1: 31.2"	"Region enhanced"	"Detected in some"		"cerebral cortex: 12.2"	"Low region specificity"	"Detected in all"			"HPA064198, HPA064230"	Enhanced		Enhanced	Mitochondria		No	No			Mitochondria		"HPA064198: AB_2685210, HPA064230: AB_2685219"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.2	0.0	0.9	1.2	1.6	0.0	0.2	0.8	1.4	0.5	29.8	0.5	0.2	29.9	0.5	1.0	0.3	2.5	11.2	0.2	0.5	0.6	15.6	4.6	1.3	0.3	0.3	0.2	1.0	4.7	0.0	0.5	0.2	0.4	0.2	2.3	12.0	0.2	0.2	0.2	0.0	77.4	0.2	0.2	0.2	0.4	0.6	0.2	0.2	5.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	8.3	1.6	0.4	14.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.1	41.7	0.0	12.9	0.1	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.2	1.0	0.0	0.0	0.0	0.1	0.1	1.2	0.2	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.5	0.0	0.4	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.7	0.0	4.4	1.4	0.0	0.0	8.3	3.2	0.0	0.2	0.0	0.0	6.6	1.6	0.9	1.6	0.8	0.4	0.5	0.6	0.3	0.2	0.4	0.2	3.0	3.7	0.8	0.0	0.0	1.0	0.8	30.6	0.0	0.0	15.7	0.0	0.0	1.7	30.8	0.4	0.0	44.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	172.8	19.9	7.0	0.0	9.5	4.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.2	0.1
MANSC1	"FLJ10298, LOH12CR3"	ENSG00000111261	"MANSC domain containing 1"	Q9H8J5	12	12326056-12350541	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	24	"neutrophil: 37.5"	"Lineage enriched"	"Detected in many"	36	"granulocytes: 37.5"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 27.2;OE19: 28.5;RPTEC TERT1: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007955, HPA007956"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		28000000	"Golgi apparatus, Vesicles"		"HPA007955: AB_1079306, HPA007956: AB_1079305"	"unprognostic (5.41e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.46e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.15e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.03e-2)"	13.1	8.8	9.7	5.1	13.7	4.2	14.7	10.1	18.4	13.5	17.8	7.5	12.9	13.4	15.1	14.1	27.3	11.2	19.3	7.9	9.2	7.6	9.5	7.6	8.4	6.6	6.9	9.0	11.3	26.4	18.5	19.5	11.0	9.0	15.0	18.5	12.8	42.6	15.2	3.6	13.3	13.3	14.4	5.8	8.4	21.3	9.1	6.2	0.0	9.5	16.7	18.2	12.6	12.9	0.2	0.2	37.5	0.5	0.2	1.0	0.1	0.1	3.0	0.9	0.0	3.1	3.0	3.3	2.1	2.5	1.1	1.4	2.5	9.7	0.0	2.3	2.0	1.1	0.4	3.8	1.7	0.8	0.0	3.4	4.3	3.8	2.0	0.5	0.6	1.2	1.9	2.9	0.7	0.5	7.6	27.2	0.1	2.7	0.0	0.3	5.7	0.0	0.3	3.4	28.5	1.6	0.1	0.0	0.0	14.1	9.9	1.3	5.4	1.1	9.1	3.1	1.6	8.2	2.7	10.6	1.5	1.3	0.4	2.8	0.2	0.1	1.4	1.1	0.0	1.1	1.5	0.5	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.2	1.0	0.1	37.5	0.2	0.1	0.0	0.0	0.1	9.7	13.7	10.1	18.4	9.2	7.6	6.9	9.0	9.0	6.2	8.9	20.5	6.9	7.0	3.5	6.8	2.1	28.1	18.7	6.8	22.7	7.9	28.7	1.7	15.0	0.8	20.4	18.1	0.0	33.2	5.4	6.9	10.2	2.3	7.5	6.5	9.5	20.8	30.1	5.9	1.8	12.7	1.4	0.0	1.0	32.2	11.7	15.8	28.1	15.6	1.6	12.6	0.0	4.7	1.7	1.5	4.1	14.2	4.4	25.5	7.2
NAGK	GNK	ENSG00000124357	"N-acetylglucosamine kinase"	Q9UJ70	2	71064344-71079805	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 191.3;Syncytiotrophoblasts: 266.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035206, HPA035207"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		690000	Cytosol	Nucleoplasm	"HPA035206: AB_2674517, HPA035207: AB_10602031"	"unprognostic (6.15e-2)"	"unprognostic (4.23e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (2.44e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.65e-3)"	"unprognostic (2.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (8.60e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.13e-2)"	20.0	17.6	21.8	30.9	24.5	9.8	15.7	13.9	18.8	23.6	15.5	23.7	17.4	11.4	16.4	19.7	67.0	13.7	20.0	14.0	17.6	20.4	16.9	20.2	18.3	30.6	31.1	20.3	15.0	25.8	27.5	21.8	43.9	26.2	15.8	15.8	14.7	49.0	17.8	11.3	29.5	14.6	22.8	21.6	43.4	15.5	24.8	26.7	20.2	13.0	27.2	39.9	24.5	26.1	14.3	53.0	37.4	79.3	8.5	7.1	52.2	19.0	15.5	8.7	8.9	34.8	21.3	34.3	42.5	18.4	28.5	25.9	18.1	10.0	10.6	10.1	29.4	33.6	9.2	6.6	12.6	17.7	15.1	5.2	6.0	5.1	11.2	26.1	3.7	15.2	19.0	13.2	30.6	4.8	20.6	29.9	9.3	2.7	12.0	39.4	17.4	9.4	13.3	9.3	15.2	12.0	7.4	24.4	5.4	17.2	34.1	9.0	5.0	12.8	20.2	13.3	15.6	10.5	4.8	26.2	34.0	13.2	13.1	14.8	8.4	7.3	6.2	23.2	10.2	18.6	10.3	79.3	31.5	5.4	69.8	5.5	14.3	6.4	5.2	53.0	13.3	5.5	4.5	37.4	8.5	46.6	42.4	7.1	52.2	21.8	24.5	13.9	18.8	17.6	20.4	31.1	20.3	26.2	26.7	35.7	38.8	52.2	25.0	23.9	42.8	14.8	22.9	24.1	28.4	36.6	21.6	111.0	34.9	60.8	114.8	28.1	13.8	0.0	39.8	106.9	36.8	15.4	49.8	12.1	191.3	44.5	22.4	30.7	107.2	16.6	27.9	97.6	37.1	45.1	18.1	42.9	52.7	22.6	35.3	46.9	53.5	19.4	33.0	33.7	22.6	36.4	266.6	23.8	13.8	37.2
NANP	"C20orf147, dJ694B14.3, HDHD4, MGC26833"	ENSG00000170191	"N-acetylneuraminic acid phosphatase"	Q8TBE9	20	25612935-25624175	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050342	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA050342: AB_2681098"	"unprognostic (8.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (6.01e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (9.01e-6)"	"unprognostic (3.20e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.42e-2)"	10.0	14.0	6.3	6.0	7.4	6.9	7.2	13.3	8.2	6.3	6.4	4.1	4.3	7.1	6.9	5.7	9.5	6.2	6.2	6.8	4.3	4.8	11.6	12.5	6.7	4.4	4.2	3.3	12.0	7.4	8.0	8.6	6.0	6.5	5.6	6.2	7.1	7.8	6.1	9.2	4.9	7.6	6.9	5.6	7.1	6.2	6.6	3.7	18.2	9.0	6.0	6.8	7.4	6.8	1.7	6.4	1.7	4.5	4.9	4.2	2.3	11.1	6.5	5.3	7.7	8.6	9.2	7.8	5.7	11.2	7.6	9.8	5.9	7.7	4.0	6.5	10.8	9.0	7.1	8.1	8.2	14.8	1.4	4.8	10.0	3.1	15.7	7.2	7.6	3.0	8.0	4.1	8.5	10.9	4.2	6.4	13.8	8.4	7.2	9.2	6.1	15.0	3.8	3.9	9.7	10.2	7.5	11.2	4.9	4.4	6.0	10.2	4.2	6.3	10.2	6.7	5.6	4.4	6.5	5.4	12.1	9.0	11.1	8.0	3.8	3.5	10.0	3.4	17.7	7.2	0.4	4.5	1.7	2.8	4.5	4.2	1.4	2.0	2.1	6.4	1.7	1.8	3.1	0.3	4.9	2.4	1.4	1.7	2.3	6.3	7.4	13.3	8.2	4.3	4.8	4.2	3.3	6.5	3.7	3.0	1.0	1.5	3.4	5.3	4.6	3.1	5.1	0.0	2.3	7.0	0.0	3.4	11.6	4.4	0.3	4.5	1.3	0.0	3.7	1.6	4.6	2.4	5.7	4.9	3.9	6.4	2.9	4.3	2.5	0.0	2.8	3.7	5.0	1.0	2.6	5.6	4.4	2.0	2.5	7.1	6.8	0.0	3.9	2.6	10.7	4.4	1.6	1.5	2.5	2.3
NANS	SAS	ENSG00000095380	"N-acetylneuraminate synthase"	Q9NR45	9	98056739-98083075	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019223	Approved		Enhanced	Nucleoplasm		No	No		200000	Nucleoplasm		"HPA019223: AB_1854298"	"unprognostic (2.95e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.79e-1)"	17.2	10.1	8.8	20.2	11.4	22.2	16.4	7.0	11.7	20.2	47.6	6.4	17.0	19.4	11.0	15.1	18.6	10.4	25.0	20.9	14.4	12.4	15.0	49.6	17.1	20.1	11.5	10.6	14.1	59.2	6.1	16.3	15.8	12.1	37.2	49.6	9.4	80.0	18.3	11.9	10.3	18.9	11.0	9.0	22.2	28.3	11.5	9.8	10.6	19.7	15.2	25.0	15.7	14.8	12.3	41.9	16.4	49.8	7.4	12.1	18.3	73.9	21.9	6.5	18.7	13.1	14.2	14.1	23.7	18.6	19.4	15.9	26.1	10.6	22.8	11.5	26.0	20.5	26.3	12.0	20.3	16.2	18.3	18.0	13.5	24.5	52.1	36.3	15.2	11.1	11.9	13.9	20.6	23.6	22.6	20.6	11.4	24.5	23.8	14.1	50.8	10.2	22.0	11.2	53.6	28.4	19.8	17.8	23.2	15.4	22.7	13.2	6.9	15.2	82.5	20.1	7.5	27.3	16.5	53.6	15.1	14.7	38.7	24.2	22.2	18.4	8.7	17.9	18.5	11.7	5.3	42.1	6.0	8.0	49.8	12.1	12.3	10.5	8.3	41.9	10.1	11.5	7.8	16.4	7.4	43.0	38.4	11.9	18.3	8.8	11.4	7.0	11.7	14.4	12.4	11.5	10.6	12.1	9.8	26.8	52.4	47.0	107.6	62.3	8.1	21.5	53.5	151.3	77.3	21.0	17.7	73.6	59.7	41.8	35.3	57.3	177.1	0.0	89.0	121.2	62.1	166.7	43.8	28.6	139.8	9.5	62.4	25.2	52.6	53.6	30.0	94.4	123.2	58.7	195.9	13.3	63.2	189.8	24.8	47.7	7.0	12.9	96.2	7.2	16.9	54.0	126.1	27.7	245.2	195.9
NPL	"C1orf13, DHDPS1, NPL1"	ENSG00000135838	"N-acetylneuraminate pyruvate lyase"	Q9BXD5	1	182789293-182830384	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.0"	"Cell type enhanced"	"Detected in many"	18	"Cytotrophoblasts: 103.5;Hofbauer cells: 387.9;Ito cells: 109.2;Kupffer cells: 121.2;Syncytiotrophoblasts: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 76.0"	"Group enriched"	"Detected in many"	36	"granulocytes: 76.0;monocytes: 23.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028345, HPA075808"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		190000	Vesicles	"Plasma membrane"	"HPA028345: AB_10610145, HPA075808: "	"unprognostic (2.43e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (4.41e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (6.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.44e-2)"	14.9	6.8	10.9	14.2	12.3	12.4	5.3	3.5	10.2	3.9	5.3	15.0	11.4	2.4	2.5	23.7	8.0	4.1	10.1	4.7	9.2	8.7	37.4	15.4	14.3	20.4	16.0	8.6	2.8	3.2	2.5	2.5	32.9	15.4	4.4	7.4	3.9	5.7	5.8	2.4	6.5	4.8	5.8	15.3	32.1	4.0	4.0	14.4	3.1	3.4	1.3	10.9	11.8	5.5	0.7	1.3	76.0	23.6	0.0	1.3	10.3	2.7	0.5	0.8	0.0	2.4	2.4	0.7	0.9	1.8	1.0	0.5	0.0	1.2	7.3	1.3	0.0	0.0	1.1	1.6	2.0	0.2	0.0	1.2	11.6	0.3	0.1	1.3	4.4	7.0	1.9	7.8	0.2	0.0	0.1	0.1	8.5	8.7	11.7	1.8	0.9	0.2	2.9	9.3	5.7	0.9	1.1	0.6	8.9	0.2	6.1	2.6	3.9	4.2	0.2	3.7	0.9	2.4	7.1	0.2	1.0	2.0	0.6	0.1	8.4	10.1	7.4	2.1	7.8	3.0	3.6	23.6	18.0	1.0	20.8	0.9	0.3	0.8	0.9	1.3	0.7	0.7	0.9	76.0	0.0	16.0	0.2	1.3	10.3	10.9	12.3	3.5	10.2	9.2	8.7	16.0	8.6	15.4	14.4	0.0	5.6	9.1	4.0	5.5	5.1	2.5	2.5	0.0	1.2	7.0	2.0	103.5	16.6	1.0	14.0	2.1	1.3	23.3	2.1	6.6	3.3	1.2	5.7	2.4	387.9	6.4	1.7	109.2	121.2	20.9	0.9	25.3	10.1	21.6	1.1	2.4	1.4	0.0	0.4	55.2	2.4	0.0	2.9	8.6	8.3	6.1	89.7	3.5	0.8	3.9
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		73000	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavorable (8.78e-4)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	15.5	16.7	11.2	10.4	13.7	4.8	12.3	19.1	13.3	15.4	10.1	9.0	30.7	8.9	10.6	26.2	10.3	8.8	14.2	12.2	11.0	8.6	12.2	44.9	13.4	6.3	13.5	9.9	15.5	36.3	9.3	36.2	27.6	18.1	30.9	13.7	7.4	29.2	23.4	5.5	7.5	11.6	11.1	9.7	8.1	14.4	16.8	11.3	4.0	14.9	7.6	8.7	11.1	10.0	8.2	7.4	11.1	6.5	5.3	8.7	3.9	10.1	6.8	13.1	15.6	21.3	22.8	15.2	34.8	25.3	16.9	26.6	17.5	4.8	5.4	7.4	34.8	17.2	6.5	11.9	14.6	32.4	4.0	11.6	6.9	13.3	29.2	24.2	6.7	3.4	14.4	12.1	29.7	37.7	17.1	19.9	3.7	22.5	5.9	18.2	10.6	1.1	4.4	5.8	9.1	9.3	4.7	29.3	3.1	13.1	10.1	5.2	8.2	10.0	9.0	7.0	20.5	7.8	7.5	28.9	11.6	6.4	23.3	18.7	11.5	4.4	3.8	9.1	5.4	18.2	11.1	6.4	3.8	5.0	6.0	6.7	8.2	5.2	6.2	5.5	5.0	8.7	8.2	2.7	5.3	6.5	7.4	3.6	3.9	11.2	13.7	19.1	13.3	11.0	8.6	13.5	9.9	18.1	11.3	26.8	20.1	3.7	21.9	14.1	16.1	5.2	20.4	12.0	28.4	10.4	9.8	27.6	6.6	29.3	40.4	10.8	14.0	23.3	43.3	56.1	40.5	76.0	4.7	30.5	15.6	7.9	15.4	16.5	4.7	15.6	31.1	8.3	10.1	12.6	25.8	25.2	36.6	17.5	17.3	18.1	20.4	6.5	18.6	54.3	31.1	13.7	53.9	7.5	15.5	17.9
RENBP	"RBP, RNBP"	ENSG00000102032	"Renin binding protein"	P51606	X	153935263-153944691	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 32.7;lymphoid tissue: 36.5"	"Cell type enhanced"	"Detected in many"	10	"granulocytes: 128.8;Hofbauer cells: 156.0;Ito cells: 72.4;Proximal tubular cells: 157.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 13.2;HMC-1: 44.8;SK-MEL-30: 29.7;U-266/84: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA000428, HPA000522"	Enhanced					NA	NA		42000			"HPA000428: AB_1079799, HPA000522: AB_1079798"	"unprognostic (3.08e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (3.08e-5)"	"unprognostic (2.39e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.51e-2)"	12.7	11.1	7.8	11.2	16.8	8.6	8.4	2.3	11.5	4.2	6.2	11.3	1.1	7.4	2.1	6.0	3.0	2.5	5.7	8.7	9.4	9.1	32.7	4.6	12.8	12.1	16.9	7.4	1.2	1.6	1.8	3.4	8.1	11.6	3.6	3.0	9.6	3.4	2.0	1.4	5.2	7.5	4.5	12.7	36.5	4.4	1.4	13.5	3.0	2.9	1.1	4.4	5.7	2.9	1.1	0.6	5.3	3.1	0.3	0.9	0.7	0.0	0.0	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.5	10.0	0.0	0.9	7.7	0.0	44.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	2.8	3.5	0.0	0.2	2.0	0.1	0.1	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	29.7	1.1	0.0	3.5	0.4	0.0	0.3	0.0	0.0	4.5	25.7	1.8	0.9	4.7	3.5	2.9	2.0	5.3	0.3	1.4	0.3	1.1	0.1	0.1	0.2	0.6	0.9	0.4	4.5	0.3	3.1	0.6	0.0	0.7	7.8	16.8	2.3	11.5	9.4	9.1	16.9	7.4	11.6	13.5	0.0	2.1	9.7	1.1	4.1	1.6	0.8	5.1	0.0	0.0	8.7	0.0	1.0	31.5	1.0	0.0	4.3	1.3	0.0	0.3	4.4	2.3	1.3	128.8	0.8	156.0	14.3	1.7	72.4	62.0	0.0	0.3	37.4	27.0	35.1	0.5	12.6	0.5	0.9	0.4	157.3	0.7	12.9	3.9	0.0	1.2	1.8	2.4	7.9	0.5	0.4
TGDS	"SDR2E1, TDPGD"	ENSG00000088451	"TDP-glucose 4,6-dehydratase"	O95455	13	94574051-94596257	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039927, HPA040857"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		Yes	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA039927: AB_10795238, HPA040857: AB_10794867"	"unprognostic (4.07e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.09e-1)"	11.1	12.2	7.9	11.4	11.8	5.8	13.4	8.0	7.8	11.9	9.0	9.0	13.4	11.1	13.7	13.2	10.3	10.5	8.7	7.7	7.0	7.0	11.8	31.9	7.8	12.5	11.8	6.8	13.9	14.1	6.2	24.3	10.8	10.1	10.5	10.6	15.4	12.5	12.7	7.6	7.9	11.1	10.3	12.6	11.9	9.8	7.2	12.6	27.1	15.8	8.9	12.5	10.9	9.2	9.9	8.0	10.5	7.0	10.4	17.4	6.7	7.4	3.1	5.2	4.7	7.7	6.2	6.5	6.8	6.5	6.4	6.2	8.5	7.3	11.4	6.9	4.7	4.2	4.7	9.2	5.3	6.6	9.0	3.6	9.2	3.6	7.9	9.8	31.4	6.3	7.2	4.2	3.6	10.3	5.1	5.9	8.4	9.0	4.0	5.8	4.5	8.6	16.2	6.9	12.0	4.0	7.3	5.3	6.7	8.1	3.3	7.4	4.1	5.1	10.8	19.0	9.1	4.8	17.1	5.5	2.6	6.8	3.9	5.6	9.1	4.9	42.1	7.0	11.7	7.0	10.5	5.3	9.6	9.6	6.2	14.5	9.9	11.3	10.5	8.0	7.3	17.4	12.4	1.5	10.4	7.0	7.1	12.5	6.7	7.9	11.8	8.0	7.8	7.0	7.0	11.8	6.8	10.1	12.6	11.9	5.0	15.6	9.5	2.2	4.5	4.7	0.0	10.7	10.3	7.0	2.0	12.9	8.3	9.8	1.1	6.3	5.5	0.0	8.0	15.4	12.0	9.9	10.5	19.8	10.0	1.6	5.2	9.2	7.6	0.4	13.3	9.6	8.5	12.6	8.1	6.3	8.2	7.0	7.8	13.3	4.0	25.8	6.4	12.0	10.4	3.1	8.7	8.7	8.0	8.7
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 107.8;U-251 MG: 70.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	Yes		19000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	38.4	18.5	7.0	17.4	9.8	17.2	24.8	9.0	13.4	16.1	26.9	5.7	45.7	17.2	10.9	19.4	23.6	15.7	18.3	22.5	7.7	7.8	11.0	67.1	16.0	7.4	6.6	8.9	20.4	31.4	5.1	16.0	21.5	9.1	13.9	26.9	7.8	43.9	62.5	19.4	12.4	33.4	28.8	7.1	8.1	23.0	37.7	3.7	5.6	12.4	13.5	15.3	24.4	16.7	8.3	5.6	8.1	1.6	6.2	16.1	4.8	30.5	2.2	6.1	4.9	29.8	23.9	4.2	44.9	16.6	34.7	28.3	5.8	14.4	1.2	10.1	34.4	12.5	5.3	6.9	13.1	57.2	4.8	10.3	5.4	7.0	11.4	14.0	9.2	3.7	11.0	6.2	38.0	107.8	15.9	21.2	9.6	30.5	12.6	46.4	5.6	5.3	5.9	4.5	31.4	10.0	4.8	11.9	14.9	5.4	3.6	6.6	6.8	19.6	12.2	10.4	7.5	6.0	10.5	36.0	17.5	16.1	44.0	70.2	21.2	7.4	10.1	10.0	4.3	11.0	1.0	1.6	8.1	13.0	1.6	16.1	8.3	7.9	13.3	3.4	6.5	7.6	9.5	1.6	6.2	0.8	5.6	3.9	4.8	7.0	9.8	9.0	13.4	7.7	7.8	6.6	8.9	9.1	3.7	6.0	30.4	17.9	120.0	119.7	10.0	26.6	17.8	53.5	38.7	15.7	7.9	22.4	61.3	24.8	36.3	23.3	84.7	0.0	56.9	52.1	141.3	91.8	33.4	88.9	14.0	6.4	52.6	21.5	7.0	11.8	46.9	15.2	81.0	27.9	124.5	14.0	55.8	69.1	38.9	20.2	12.3	19.4	160.3	182.9	121.8	71.5	81.7	20.1	59.9	111.6
UAP1L1		ENSG00000197355	"UDP-N-acetylglucosamine pyrophosphorylase 1 like 1"	Q3KQV9	9	137077501-137084539	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 18.6;Horizontal cells: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044356	Approved		Approved	"Intermediate filaments,Cytosol"		No	No			"Intermediate filaments"	Cytosol	"HPA044356: AB_10959902"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.80e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.65e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.64e-3)"	10.5	14.7	13.6	9.8	20.6	5.0	16.3	3.4	17.5	13.0	8.8	22.1	8.6	10.0	7.3	9.7	5.9	5.8	9.4	11.3	14.7	8.1	12.5	3.1	11.6	12.2	24.9	9.3	3.9	10.5	8.5	14.7	10.9	14.2	12.8	6.7	14.1	15.2	10.9	2.5	9.0	9.4	6.6	13.5	20.3	10.8	3.5	29.1	1.4	13.3	4.9	10.3	11.4	13.9	2.1	1.8	0.6	3.7	0.3	3.0	1.2	0.4	2.8	0.0	7.5	13.0	6.1	2.2	3.8	10.1	10.8	7.6	5.4	1.2	1.7	2.3	3.9	19.7	5.8	14.1	0.9	2.2	4.6	1.2	3.7	4.2	5.2	29.0	0.0	15.3	4.4	1.0	6.1	5.1	5.1	8.4	3.5	1.1	8.6	7.2	6.2	0.3	3.7	1.2	13.2	4.0	5.9	0.1	5.2	4.3	0.5	4.5	2.8	0.9	21.2	8.6	1.9	11.4	10.2	6.6	19.6	4.2	13.6	1.8	9.5	13.5	3.6	17.0	4.0	5.5	0.4	3.7	0.1	0.8	2.0	3.0	2.1	0.4	1.3	1.8	1.0	1.0	1.3	0.6	0.3	0.0	1.1	1.7	1.2	13.6	20.6	3.4	17.5	14.7	8.1	24.9	9.3	14.2	29.1	0.0	5.9	2.9	0.5	5.5	4.8	3.5	7.6	0.0	1.2	0.0	2.0	0.3	10.0	1.3	0.1	2.1	0.2	0.0	0.8	4.6	4.4	1.9	4.6	0.2	18.6	19.1	1.7	7.4	12.7	0.0	2.3	8.1	8.5	5.4	1.7	6.5	0.9	1.9	3.5	3.1	4.7	0.0	3.4	0.5	1.5	3.9	1.1	2.6	2.3	0.1
UXS1	"FLJ23591, SDR6E1, UGD"	ENSG00000115652	"UDP-glucuronate decarboxylase 1"	Q8NBZ7	2	106093303-106194339	"Enzymes, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008825	Uncertain				"Intracellular and membrane"	NA	NA		10000			"HPA008825: AB_1858708"	"unprognostic (4.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (5.45e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.20e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.94e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.32e-2)"	12.3	11.7	15.2	17.3	19.9	20.7	20.1	23.0	20.5	14.1	13.3	11.9	27.6	9.5	16.1	22.3	15.6	19.2	16.2	20.0	17.0	18.2	40.2	16.1	28.8	20.7	15.1	11.6	16.3	17.0	18.6	13.4	37.9	19.6	16.2	15.6	14.7	11.6	17.6	18.0	11.5	9.9	13.8	22.9	19.7	17.9	19.4	10.6	15.0	26.2	14.1	19.1	21.6	15.3	11.6	7.5	11.2	9.8	11.9	34.1	15.1	16.5	12.5	13.2	10.0	23.6	17.6	28.6	18.3	17.2	13.0	16.2	24.5	28.3	3.0	22.8	18.9	29.2	8.4	5.7	15.0	14.2	15.9	10.0	9.1	5.6	27.5	9.3	7.4	10.1	11.4	16.6	13.2	8.9	15.1	13.6	5.8	5.3	7.3	26.8	11.8	8.2	15.9	15.5	16.0	16.8	15.3	10.0	8.5	83.9	15.6	4.4	4.9	13.1	11.8	10.8	18.6	4.4	23.6	12.2	14.6	15.3	11.8	11.3	9.0	12.4	4.1	14.5	16.6	26.7	3.9	9.8	11.2	8.8	8.0	9.5	4.9	19.6	14.3	7.5	11.6	25.4	17.6	2.0	11.9	5.3	5.4	34.1	15.1	15.2	19.9	23.0	20.5	17.0	18.2	15.1	11.6	19.6	10.6	83.4	72.6	12.3	22.3	14.9	9.1	15.3	22.9	29.4	61.4	82.0	3.9	59.1	43.1	42.5	42.6	18.9	11.0	23.3	21.9	60.0	31.9	15.7	28.9	12.9	29.5	7.9	6.3	8.6	19.8	11.4	14.1	25.4	13.5	80.2	14.3	10.0	25.7	10.5	12.0	16.7	6.8	19.4	20.8	11.9	59.8	11.5	20.6	30.5	19.9	15.5
